Sensex

Nifty

USDINR

GBPINR

EURINR

Wednesday, 19 November 2025 12:00 AM EOD	Asian-Paints2893.85	Hind-Unilever2440.75	ITC403.55	Trent4358.10	Larsen-and-Toubro4019.30	M-and-M3722.20	Reliance-Industr1518.65	Tata-Motors-PVeh360.90	Tata-Steel173.10	Titan-Company3932.75	SBI982.45	Bharat-Electron423.40	Kotak-Mah-Bank2106.10	Infosys1541.25	Bajaj-Finance1005.55	Sun-PharmaInds1784.15	HDFC-Bank994.65	TCS3147.20	ICICI-Bank1383.10	Power-Grid-Corpn275.25	Maruti-Suzuki15759.00	Axis-Bank1270.05	HCL-Technologies1663.00	NTPC326.65	Bharti-Airtel2161.30	Tech-Mahindra1438.20	Adani-Ports1483.70	UltraTech-Cem11664.90	Bajaj-Finserv2050.10	Eternal-Ltd306.50
15 mins delay SENSEX 85,186.47 [513.45]	-11.65 -0.40%	37.10 1.54%	-2.20 -0.54%	-13.60 -0.31%	20.35 0.51%	26.10 0.71%	-1.00 -0.07%	-10.35 -2.79%	0.70 0.41%	49.45 1.27%	9.90 1.02%	2.55 0.61%	14.25 0.68%	55.60 3.74%	-8.00 -0.79%	24.45 1.39%	3.05 0.31%	61.55 1.99%	11.20 0.82%	1.05 0.38%	-169.85 -1.07%	4.80 0.38%	68.25 4.28%	-1.90 -0.58%	11.40 0.53%	17.10 1.20%	-11.30 -0.76%	-41.45 -0.35%	-0.35 -0.02%	0.60 0.20%

Company News

Sun Pharmaceutical Industries Ltd

Astrazeneca Pharma and Sun Pharma form second brand partnership

Nov 17,2025

Astrazeneca Pharma India and Sun Pharmaceutical Industries announced a second brand partnership for Sodium Zirconium Cyclosilicate (SZC) in India. This exclusive agreement is aimed at further accelerating availability of SZC, an innovative and highly effective treatment for Hyperkalaemia to more patients across India. Under the agreement, both companies will promote, market & distribute SZC in India under different brand names; AstraZeneca will market SZC as Lokelma® whereas Sun Pharma will promote and distribute the therapy as Gimliand®. AstraZeneca will retain the intellectual property rights to SZC and hold the Marketing Authorisation along with the import license of the molecule.

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

A Muthoot M George Enterprise